Aequus Reports 2nd Quarter 2022 Economic Highlights and Standard Update

Elwanda Tulloch

Aequus Prescription drugs VANCOUVER, British Columbia, Aug. 29, 2022 (World NEWSWIRE) — Aequus Prescription drugs Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical enterprise with a concentration on establishing, advancing, and advertising and marketing differentiated goods, has employed Rabin Ramanjooloo as Director of Functions and nowadays […]

SIGMA LITHIUM PROVIDES UPDATE FROM A TRANSFORMATIVE SECOND QUARTER, APPOINTS COO FOR OPERATIONAL READINESS AND PREPARING PHASE 1 PIT FOR MINING

Elwanda Tulloch

COMMENTS FROM MANAGEMENT From Ana Cabral-Gardner, Co-CEO of Sigma Lithium. “We are delighted to have further strengthened our operational team by adding industry-leading executives, rounding out a world-class management team at Sigma Lithium. Having achieved all of our execution milestones to date, delivering a transformational quarter demonstrates the ability of this team […]

Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2022 Financial Results

Elwanda Tulloch

Quoin Pharmaceuticals, Inc. Initiates clinical trial evaluating lead product candidate, QRX003 for Netherton SyndromeExpands number of commercial partnerships to eight, covering 60 countriesSigns Research Agreement to develop a product for the treatment of scleroderma Closes $16.8 million public offering, with net proceeds of approximately $15.0 million ASHBURN, Va., Aug. 18, […]

Subscribe US Now